IP Library Granted Patent US 7,659,080
Granted Patent B2
US 7,659,080 · App. 11/897,494 · Granted Feb 9, 2010

Detecting a bacterial process in chronic rhinosinusitis

Assignees: The Research Foundation of State University of New York; Mayo Foundation For Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,659,080
App. No.
11/897,494
Granted
Feb 9, 2010
Kind
B2
Abstract

The present invention provides a method for identifying bacterial induced rhinosinusitis. The method comprises obtaining a nasal or paranasal mucus sample and detecting the presence of neutrophil degranulation in the mucus sample. Degranulation of neutrophils can be determined by morphological analysis of the cells in the mucus or by detection of released (i.e., “free”) granule content markers such as neutrophil elastase or myeloperoxidase. Based on an accurate determination of the cause of sinusitis as described herein, an appropriate treatment can be instituted.

Claims (10)

1. A method of detecting bacterial sinusitis in an individual comprising the steps of:

(a) collecting nasal or paranasal mucus sample from the individual;

(b) processing the mucus sample by a process which is not expected to cause breakup of neutrophils and

(c) selectively detecting the presence of the free neutrophil granule content marker, neutrophil elastase, released by the neutrophils in the mucus sample;

wherein the presence of the free neutrophil elastase released by the neutrophils in the mucus sample compared to a mucus sample from a healthy normal control is indicative of the bacterial sinusitis in the individual.

2. The method of claim 1 , wherein the collected mucus sample is centrifuged to obtain a supernatant and the free neutrophil elastase is detected in the supernatant.

3. The method of claim 2 , wherein the mucus sample is processed without homogenization.

4. The method of claim 1 , wherein the neutrophil elastase is detected using an antibody or an antigen binding fragment thereof specific for the neutrophil elastase.

5. The method of claim 1 further comprising the step of detecting selectively the presence of eosinophil degranulation in the mucus sample.

6. The method of claim 5 , wherein the eosinophil degranulation is detected by identifying the presence of free major basic protein in the mucus sample.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 23, 2012
From: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029176/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2008
From: PONIKAU, JENS; SHERRIS, DAVID
To: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Reel/Frame 020873/0027 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2008
From: KITA, HIROHITO
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 020873/0131 →
Continuity (2)
Provisional Application 6084106200 · Aug 30, 2006
Related Publication 20080090252A1 · Apr 17, 2008